Stock listing

F6T Stock Price, News, Filings & Events — Fate Therapeutics, Inc.

Selected listing: F6T · FWB · EUR · DE

F6T:FWB is the public listing for Fate Therapeutics, Inc., a biotechnology company dedicated to developing cellular immunotherapies for cancer and immune disorders. Based in the United States, the company is focused on advancing innovative therapies through extensive research and development in regenerative medicine. With a market capitalization of approximately €280.9 million, Fate Therapeutics continues to make strides in the biotech sector, contributing to advancements in treatment options for patients. Recent news and filings may provide insights into the company's ongoing projects and market positioning.